Shengnan Huang

Senior Postdoctoral Associate
Department
David H Koch Institute for Integrative Cancer Res
Technology Areas
Biotechnology: Synthetic Biology / Therapeutics: Proteins & Antibodies, Vaccines / Drug Discovery and Research Tools: Genomics & Proteomics
Impact Areas
Healthy Living

Technologies

Reprogram the Genome of M13 Phage for Vaccination and Immunotherapy Applications

Technology / Case number: #25169
Shengnan Huang / Angela Belcher
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Engineering Immune Checkpoint Blockade Nanobody-STINGTM Fusion Protein As A Versatile Treatment For Solid Tumor Cancers

Technology / Case number: #24323
Yanpu He / Shengnan Huang / Angela Belcher
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Recombinant Transmembrane Domain-Deficient STING as Biomimetic Protein Carrier for cGAMP Enhanced Cancer Immunotherapy

Technology / Case number: #25012
Jiahe Li / Yanpu He / Shengnan Huang / Celestine Jia Huey Hong / Paula Hammond / Angela Belcher
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up